UBS Group AG - ARRHYTHMIA RESH TECHNOLOGY I ownership

ARRHYTHMIA RESH TECHNOLOGY I's ticker is HRT and the CUSIP is 042698308. A total of 17 filers reported holding ARRHYTHMIA RESH TECHNOLOGY I in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ARRHYTHMIA RESH TECHNOLOGY I
ValueSharesWeighting
Q4 2016$13,000
-13.3%
3,401
-7.0%
0.00%
Q3 2016$15,0000.0%3,656
+9.5%
0.00%
Q2 2016$15,000
+25.0%
3,340
+23.5%
0.00%
Q1 2016$12,0000.0%2,705
+20.7%
0.00%
Q4 2015$12,000
-7.7%
2,242
+4.4%
0.00%
Q3 2015$13,000
+62.5%
2,148
+98.3%
0.00%
Q1 2015$8,0001,0830.00%
Other shareholders
ARRHYTHMIA RESH TECHNOLOGY I shareholders Q1 2016
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 66,944$294,554,0000.27%
SHEPHERD KAPLAN KROCHUK, LLC 16,900$74,0000.02%
Renaissance Technologies 94,000$414,0000.00%
UBS Group AG 3,340$15,0000.00%
Nationwide Fund Advisors 200$1,0000.00%
FMR LLC 77,200$340,0000.00%
DIMENSIONAL FUND ADVISORS LP 56,453$248,0000.00%
BANK OF AMERICA CORP /DE/ 80$00.00%
WELLS FARGO & COMPANY/MN 1$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 26,800$118,0000.00%
View complete list of ARRHYTHMIA RESH TECHNOLOGY I shareholders